Pubdate: Wed, 08 Feb 2006 Source: Salmon Arm Observer (CN BC) Copyright: 2006 Salmon Arm Observer Contact: http://www.saobserver.net/ Details: http://www.mapinc.org/media/1407 Author: Lachlan Labere DRUGS REMAIN Decongestants: B.C. Chooses to Leave Products on Shelves. There is no plan for B.C. pharmacies to move common decongestants behind the counter to counter the production of crystal meth. Although the National Association of Pharmacy Regulatory Authorities (NAPRA), an umbrella association of Canada's pharmacy regulatory authorities, has recommended that pharmacies move over-the-counter cold and allergy medications such as Sudafed, in which the sole ingredient is pseudoephedrine, behind the counter as of April 10, the final decision on the matter is up to the pharmacy regulatory authorities of individual provinces. NAPRA has also recommended that pseudoephedrine-based products be removed entirely from the shelves of grocery stores and other markets without pharmacies. These recommendations are in response to growing national concerns over crystal methampetamine use and production, in which pseudoephedrine is a key ingredient. While other provinces may adopt NAPRA's recommendations, B.C.'s own pharmaceutical authority, the College of Pharmacists of British Columbia (CPBC), has elected to allow pharmacies and grocery stores that sell Sudafed and similar products to do so as they are now. "In other provinces, like in Sask? atchewan, they've pulled it behind the counter and they have pulled it out of grocery stores," said Fran Burman, pharmacist and pharmacy co-manager of Salmon Arm's Pharmasave. "But in B.C., it's an individual store's decision whether they want to do that or not. But there are going to be no regulations because they have no way to enforce this." As an alternative, the B.C. college endorses the Meth Watch Program, a national program created to curtail suspicious sales of pseudoephedrine products and other household products used in the production of crystal meth. Burman noted Pharmasave is a member of the Meth Watch Program, and that she herself is a member of Salmon Arm's crystal meth task force. "We don't see the problems here," said Burman. "We have brochures at the back and at the front for staff so they know which products are being used for crystal meth so they can look for any bulk buying." NAPRA's recommendations regarding pseudoephedrine follow the Dec. 28, 2005, recall by Health Canada of Kaizen Ephedrine tablets. Used for weight loss and increased energy, these tablets, containing a similar chemical formula to pseudoephedrine, were found to have potentially fatal adverse effects including dizziness, headaches, heart attacks and stroke. In 2002 Health Canada recalled products containing ephedra/ephedrine, after these products were found to have adverse effects including stroke, heart attacks, seizures, psychosis and deaths. - --- MAP posted-by: Richard Lake